Dermatology: 844-562-3376 | Gastroenterology: 785-354-8518 | Plastic Surgery: 785-271-2297
Kansas Medical Clinic, PA

Clostridium Difficile (C-DIFF)

This study will evaluate efficacy and safety information about RBX2660 for the treatment of recurrent Clostridium difficile infection (CDI). Enrolled subjects will receive one treatment with RBX2660 (microbiota suspension).

KMC Dermatology

Topeka, Lawrence, Emporia, Manhattan, Kansas City, Shawnee, Leawood, Olathe

KMC Gastroenterology

785-354-8518
2200 SW 6th Ave.
Topeka, KS 66606

Disclaimer

All information provided herein is for educational purposes only. If you have a medical condition, please consult a physician to get a proper diagnosis and treatment plan.

© Copyright 2018 - Kansas Medical Clinic, PA